Product Specs FIBRYGA
Manufacturer Name Octapharma
Indications FIBRYGA is indicated for the treatment of acute bleeding episodes in adults and adolescents with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia
Contraindications Anaphylactic or severe reactions to FIBRYGA or its components.
Viral Safety Process Solvent/detergent and nanofiltration
Product Half-Life 75.9 ± 23.8 hours
Manufacturing Method Human-Derived Plasma
Storage Requirements/Shelf Life
  • Store at 2°C to 25°C (36°F to 77°F) for up to 30 months from date of manufacture.
  • Do not freeze. Store in the original container to protect from light.
  • After reconstitution, do not refrigerate or freeze.
  • Use the reconstituted solution immediately or within 4 hours.
  • Nominal Vial Size & Diluent Volume 1 g/50 mL

    Return to Manufacturer Name listing Return to Factor Type listing